Among the 2,351 persons on whom eligibility was determined, 60.8% were scheduled for an enrollment visit; of these, 1,140 (81.3%) were enrolled and tested.
For Stanford Health Care SHC Health & Welfarere benefits information and/or enrollment, visit the HealthySteps Benefits Portal at www.healthysteps4u.org.healthysteps4u.org
All participants provided written informed consent as part of the enrollment visit.
Subjects completed the FLIE, KDQOL-36,™ EQ-5D-5 L, sPGA, and PGRC on eDiaries before dialysis during the enrollment visit.
Each participated in three protocol-driven clinic visits: Day 1 (Enrollment: Visit 1), Day 7 ± 3 days (Visit 2), and Day 28 ± 4 days (Visit 3).
These recordings were obtained at the pre-HIRREM enrollment visit, just prior to the assessment of the pattern of brain electrical frequencies and amplitudes, and again during the post-HIRREM data collection visit.
Study participation includes a baseline enrollment visit consisting of informed consent, completion of self-report inventories, short-term recording of blood pressure and heart rate, and a HIRREM assessment.
HPV testing was performed on CVL specimens taken at the enrollment visit.
At the enrollment visit, participants received a second informed consent explaining the details of the study.
At the enrollment visit, swabs of vaginal fluid samples were collected for Gram staining, pH, saline microscopy and KOH preparation.
Proteinuria was defined as the presence of ≥+1 protein on a single urine specimen obtained at the enrollment visit.
